Adarsh Krishnan Sundara Rajan/LinkedIn
Sep 18, 2026, 16:51
Adarsh Krishnan Sundara Rajan: Is VTE the Most Underdiagnosed Critical Threat in Modern Healthcare?
Adarsh Krishnan Sundara Rajan, Director Of Strategic Sourcing at Diagnostic Care and Trading (DCT), shared a post on LinkedIn:
”Is VTE the most underdiagnosed critical threat in modern healthcare?
According to recent Global Burden of Disease data published in The Lancet Group, cardiovascular and thrombotic complications remain among the leading global causes of mortality.
Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) are particularly dangerous because they are largely asymptomatic until a major event occurs.
Key takeaways from this piece:
- Silent Danger: Over 90 percent of early-stage thrombi develop without noticeable symptoms.
- High-Risk Profiles: Oncology, post-surgical, and long-term bedridden patients require heightened surveillance.
- The Role of Early Diagnostics: Combining clinical risk stratification with multi-marker biomarker panels substantially improves early detection and allows for timely anticoagulant intervention.
Question for my network: How is your organization or health system approaching preventative screening for VTE in high-risk inpatient departments?”
Stay updated with Hemostasis Today․
-
Sep 18, 2026, 16:19CRISPR and Hemophilia: The Next Frontier of In Vivo Gene Editing
-
Sep 18, 2026, 16:13Christian Irsara: PF4 Immunothrombosis Following Natural Adenovirus Infection
-
Sep 18, 2026, 16:10Leo Nicolai։ The Spleen Emerges as a Key Regulator of Thromboinflammation
-
Sep 18, 2026, 16:05Targeting Factor XI to Reduce Thrombosis Without Compromising Hemostasis – ISTH
-
Sep 18, 2026, 15:54Swapnil Pawar: Why Aren’t We Using Cryopreserved Platelets Everywhere Yet?
-
Sep 18, 2026, 15:37Abdul Mannan: Evaluating Longitudinal Platelet Trends Beyond Standard Reference Intervals
-
Sep 18, 2026, 15:30Peter A. Everts։ Platelet Phenotype May Hold the Key to More Consistent PRP Therapy
-
Sep 18, 2026, 15:25Brandon Temple: Turning Personal Experience Into Advocacy for wAIHA Research
-
Sep 18, 2026, 15:01A. M. Thirugnanam: Antiplatelet Discontinuation and the Risk of Stent Thrombosis